Nirogacestat Linked With Improved Functional Status in Patients With Desmoid Tumors
April 9th 2024Results presented at the National Community Oncology Dispensing Association International Spring Forum describe meaningful improvements in functioning among patients who received the oral gamma secretase inhibitor to treat progressing desmoid tumors.
Read More
FDA Approves Nirogacestat for Treatment of Desmoid Tumors
November 28th 2023Desmoid tumors are noncancerous growths that appear in connective tissue, most often on the arms, legs, and abdomen. Aggressive tumors must be treated with surgery, radiation, or chemotherapy to keep them from growing into nearby organs, which can make them life threatening. They can cause pain and disfigurement, and they can reduce functioning and quality of life.
Read More